Peer Schatz

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Part of QIAGEN NV, QIAGEN Manchester Ltd. is a pharmaceutical manufacturing company. The company is based in Manchester, UK. QIAGEN Manchester was founded in 2001.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Part of QIAGEN NV, QIAGEN Manchester Ltd. is a pharmaceutical manufacturing company. The company is based in Manchester, UK. QIAGEN Manchester was founded in 2001.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Qiagen SRL is engaged in providing assay technologies. The company is headquartered in Milan, Italy.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Intelligent Bio-Systems is developing a next generation DNA sequencing system that can simultaneously increase the speed and reduce the cost of producing sequence data by a factor of 100 to 1,000. It uses a proprietary chemistry, high-density chip and fluorescent instrument system to accurately decode the sequence of DNA fragments. The technology has the potential to dramatically change the way research is performed and healthcare is delivered.

Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.

QIAGEN Lake Constance GmbH develops and produces optical measurement devices for medical, environmental and industrial applications. The company was founded by Thomas Wiest, Klaus Haberstroh, Roland Sackers, Peer Michael Schatz, and Jörg Schickedanz in 1997 and is headquartered in Stockach, Germany.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Parsagen Diagnostics, Inc. provides health care and biotechnology services. The company was founded in 2014 and is headquartered in Germantown, MD.

Amnisure International LLC manufactures and distributes medical assays in determining the presence of a rupture of fetal membranes in pregnant women. The firm’s technology includes Amnisure ROM test, PAMG-1 Protein, Lateral Flow, Alpha Fetoprotein and Biomarker Testing for PROM and Non-Invasive PROM & pPROM testing. The company was founded in 2005 and is headquartered in Boston, MA.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom.

DxS Ltd. is a personalized medicine company which engages in the development and manufacture of companion diagnostic products. Its products make use of molecular diagnostics to aid doctors and drug companies in selecting therapies for patients. It offers its products, technology, and services to the healthcare industry to enable the delivery of safe and effective medicines. The company was founded by David Whitcombe in 2001 is headquartered in Manchester, the United Kingdom.

Intelligent Bio-Systems is developing a next generation DNA sequencing system that can simultaneously increase the speed and reduce the cost of producing sequence data by a factor of 100 to 1,000. It uses a proprietary chemistry, high-density chip and fluorescent instrument system to accurately decode the sequence of DNA fragments. The technology has the potential to dramatically change the way research is performed and healthcare is delivered.

Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Siemens Healthcare GmbH provides healthcare services. Its products and services include medical imaging, ultrasound, laboratory diagnostics, point-of-care testing, healthcare, clinical specialties & diseases. It operates through following business segments: Imaging, Diagnostics and Advanced Therapies. The Imaging segment offers diagnostic imaging products and a broad portfolio of advanced imaging and ultrasound systems and solutions. The Diagnostics segment offers products, services and solutions, including a broad array of testing applications, in the areas of laboratory, point of care and molecular diagnostics. The Advanced Therapies segment is a supplier of advanced therapy products, services and solutions to the therapy departments of healthcare providers. The company was founded on May 1, 2015 and is headquartered in Erlangen, Germany.

Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.

Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Centogene AG focuses on genetic and biochemical diagnostic testing services for rare hereditary disorders. The firm operates through the offices located in Freiburg, Dubai and Noida. The company was founded by Arndt Rolfs in 2006 and is headquartered in Rostock, Germany.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

QIAGEN Lake Constance GmbH develops and produces optical measurement devices for medical, environmental and industrial applications. The company was founded by Thomas Wiest, Klaus Haberstroh, Roland Sackers, Peer Michael Schatz, and Jörg Schickedanz in 1997 and is headquartered in Stockach, Germany.

Qiagen Ltd. engages in other human health activities. The company was incorporated on October 4, 1993 and is headquartered in Manchester, the United Kingdom

Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Resolve BioSciences GmbH is a German company that applies molecular cartography to provide scientists with a high-resolution view of spatial biology. The company is based in Monheim am Rhein, Germany. The company's proprietary technology offers full spatial context at subcellular resolution, which helps scientists detect individual transcripts and rare signals to interpret fundamental biology. The company's technology is used in critical fields such as oncology, neuroscience, infectious disease, and agriculture. The company was founded by Jason T. Gammack, and John Stark has been the CEO of the company since 2023.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Qiagen Beverly, Inc. produces reagents, kits and assays enables customers worldwide to transform patient treatment and life science research. Its products include xmal, mapl, taqiT, wgs ligase, sall, xhol and bamhi. The company was founded by Christopher Benoit and Stephen Picone in 2006 and is headquartered in Beverly, M A.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.

Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia.

Forum Mondial de L'Economie engages in the foremost political, business and cultural organizations to shape global, regional and industry agendas. The company was founded by Klaus Schwab in 1971 and is headquartered in Cologny, Switzerland.